216 related articles for article (PubMed ID: 19116753)
1. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
2. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
3. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of a new small-bore percutaneous pleural catheter used for treatment of malignant pleural effusions in ECOG PS 3-4 patients.
Filosso PL; Sandri A; Felletti G; Ruffini E; Lausi PO; Oliaro A
Eur J Surg Oncol; 2011 Dec; 37(12):1093-8. PubMed ID: 21963043
[TBL] [Abstract][Full Text] [Related]
5. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
6. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
[TBL] [Abstract][Full Text] [Related]
7. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients.
Ak G; Metintaş M; Yildirim H; Metintaş S; Dündar E; Erginel S; Alataş F
Tuberk Toraks; 2009; 57(1):22-31. PubMed ID: 19533434
[TBL] [Abstract][Full Text] [Related]
8. [The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].
Hoksch B; Seidel N; Beshay M; Schmid RA
Zentralbl Chir; 2010 Feb; 135(1):54-8. PubMed ID: 20029741
[TBL] [Abstract][Full Text] [Related]
9. Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions.
Hunt BM; Farivar AS; Vallières E; Louie BE; Aye RW; Flores EE; Gorden JA
Ann Thorac Surg; 2012 Oct; 94(4):1053-7; discussion 1057-9. PubMed ID: 22513274
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.
Neto JD; de Oliveira SF; Vianna SP; Terra RM
Respirology; 2010 Jan; 15(1):115-8. PubMed ID: 19947987
[TBL] [Abstract][Full Text] [Related]
11. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?
Terra RM; Junqueira JJM; Teixeira LR; Vargas FS; Pêgo-Fernandes PM; Jatene FB
Chest; 2009 Aug; 136(2):361-368. PubMed ID: 19349389
[TBL] [Abstract][Full Text] [Related]
12. Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience.
Bertolaccini L; Viti A; Gorla A; Terzi A
Eur J Surg Oncol; 2012 Dec; 38(12):1161-4. PubMed ID: 22959168
[TBL] [Abstract][Full Text] [Related]
13. A propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy.
Freeman RK; Ascioti AJ; Mahidhara RS
Ann Thorac Surg; 2013 Jul; 96(1):259-63: discussion 263-4. PubMed ID: 23673067
[TBL] [Abstract][Full Text] [Related]
14. Recurrent pleural effusion: who benefits from a tunneled pleural catheter?
Schneider T; Reimer P; Storz K; Klopp M; Pfannschmidt J; Dienemann H; Hoffmann H
Thorac Cardiovasc Surg; 2009 Feb; 57(1):42-6. PubMed ID: 19169996
[TBL] [Abstract][Full Text] [Related]
15. What is the best treatment for malignant pleural effusions?
Zahid I; Routledge T; Billè A; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):818-23. PubMed ID: 21325469
[TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality within three months in the patients with malignant pleural effusion.
Ozyurtkan MO; Balci AE; Cakmak M
Eur J Intern Med; 2010 Feb; 21(1):30-4. PubMed ID: 20122610
[TBL] [Abstract][Full Text] [Related]
17. The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions.
Habal P; Jankovicova K; Omran N; Kondelkova K; Krejsek J; Mandak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):311-5. PubMed ID: 23235721
[TBL] [Abstract][Full Text] [Related]
18. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters.
Suzuki K; Servais EL; Rizk NP; Solomon SB; Sima CS; Park BJ; Kachala SS; Zlobinsky M; Rusch VW; Adusumilli PS
J Thorac Oncol; 2011 Apr; 6(4):762-7. PubMed ID: 21325982
[TBL] [Abstract][Full Text] [Related]
19. [Monitoring the effectiveness of surgical treatment of malignant pleural effusions].
Habal P; Mand'ák J; Simek J; Stĕtina M; Jankovicová K; Kondĕlková K; Krejsek J
Klin Onkol; 2010; 23(2):99-103. PubMed ID: 20465088
[TBL] [Abstract][Full Text] [Related]
20. Talc pleurodesis for the management of malignant pleural effusions in Japan.
Inoue T; Ishida A; Nakamura M; Nishine H; Mineshita M; Miyazawa T
Intern Med; 2013; 52(11):1173-6. PubMed ID: 23728550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
